The calculation and use of carcinogenic potency: a review.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Regulatory toxicology and pharmacology : RTP

• Publication date

  1985-12-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/0273-2300(85)90008-XPMID 3912853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The LD50 test and in vitro toxicology strategies.

  2009cited by this paper
• Complete programme for acute toxicity testing - not only LD50 determination.

  2009cited by this paper
• The LD50 test.

  2009cited by this paper
• Shortcomings of LD50-values and acute toxicity testing in animals.

  2009cited by this paper
• Computer methods for the assessment of toxicity.

  2009cited by this paper
• LD50 - its value for the pharmaceutical industry in safety evaluation of drugs.

  2009cited by this paper
• Dose-response relationships for mutations induced in E. coli by some model compounds. With an addendum: Reaction kinetics in water of chloroethylene oxide, chloroacetaldehyde, and chloroacetone.

  2008cited by this paper
• Registry of Toxic Effects of Chemical Substances

  1986cited by this paper
• Experimental design of bioassays for screening and low dose extrapolation.

  1985cited by this paper
• Lack of concordance of the Salmonella/microsome assay with the mouse dermal carcinogenesis bioassay for complex petroleum hydrocarbon mixtures.

  1985cited by this paper
• Lack of miscoding properties of 7-(2-oxoethyl)guanine, the major vinyl chloride-DNA adduct.

  1985cited by this paper
• Some Tautologous Aspects of the Comparison of Carcinogenic Potency in Rats and Mice

  1985cited by this paper
• Carcinogenic effect of nitrosoalkylureas and nitrosoalkylcarbamates in Syrian hamsters.

  1985cited by this paper
• Correlation of initiating potency of skin carcinogens with potency to induce resistance to terminal differentiation in cultured mouse keratinocytes.

  1985cited by this paper
• Design of cancer assays for pharmaceutical agents.

  1985cited by this paper
• Some tautologous aspects of the comparison of carcinogenic potency in rats and mice.

  1985cited by this paper
• Quantitative Approaches for Cancer Risk Assessment1

  1985cited by this paper
• Relationship between mutagenic potency in Salmonella typhimurium and chemical structure of amino- and nitro-substituted biphenyls.

  1985cited by this paper
• Two-stage tumor promotion in mouse skin: an alternative interpretation.

  1985cited by this paper
• A quantitative comparison of a percentile rule with a 2-fold rule for assessing mutagenicity in the Ames assay.

  1985cited by this paper
• Mutagenicity in drug development: interpretation and significance of test results.

  1985cited by this paper
• Quantitative approaches for cancer risk assessment.

  1985cited by this paper
• Prediction of in vivo tumor response to chemotherapeutic agents by the in vitro sister chromatid exchange assay.

  1985cited by this paper
• The TD50: a proposed general convention for the numerical description of the carcinogenic potency of chemicals in chronic-exposure animal experiments.

  1984cited by this paper
• Relationships between the electrostatic potential, epoxide hydrase inhibition and carcinogenicity for some hydrocarbon and halogenated hydrocarbon epoxides.

  1984cited by this paper
• An analysis of the spectra of genetic activity produced by known or suspected human carcinogens.

  1984cited by this paper
• Occupational formaldehyde exposure and increased nasal cancer risk in man

  1984cited by this paper
• Prediction of environmental carcinogens: a strategy for the mid-1980s.

  1984cited by this paper
• Tradescantia-Micronucleus (Trad-MCN) tests on 140 health-related agents.

  1984cited by this paper
• The application of mutagenicity tests to the prediction of carcinogenic activity of chemicals and drugs.

  1984cited by this paper
• Report of ICPEMC Task Group 5 on the differentiation between genotoxic and non-genotoxic carcinogens.

  1984cited by this paper
• Quantitative comparisons of acute toxicity of organic chemicals to rat and fish.

  1984cited by this paper
• Implications of multiple mechanisms of carcinogenesis for short-term testing.

  1984cited by this paper
• Chemicals showing no evidence of carcinogenicity in long-term, two-species rodent studies: the need for short-term test data.

  1984cited by this paper
• Results from 86 two-year carcinogenicity studies conducted by the National Toxicology Program.

  1984cited by this paper
• Summary of carcinogenicity data generated by the National Cancer Institute/National Toxicology Program.

  1984cited by this paper
• Tackling a Very Difficult Problem

  1984cited by this paper
• DNA binding spectrum of the carcinogen N-acetoxy-N-2-acetylaminofluorene significantly differs from the mutation spectrum.

  1984cited by this paper
• Occupational cancer: problems in interpreting human evidence.

  1984cited by this paper
• Estimation of the dermal carcinogenic activity of petroleum fractions using a modified Ames assay

  1984cited by this paper
• Use of biotechnology in the production of single-cell protein

  1984cited by this paper
• Carcinogenicity testing and safety assessment.

  1984cited by this paper
• Structure‐activity relationship studies on the toxicities of benzene derivatives: I. An additivity model

  1984cited by this paper
• A new paradigm is needed in toxicology evaluation.

  1984cited by this paper
• A new method for determining allowable daily intakes.

  1984cited by this paper
• Evaluation of pesticides which pose carcinogenicity potential in animal testing. I. Developing a tumor data evaluation system.

  1984cited by this paper
• A carcinogenic potency database of the standardized results of animal bioassays

  1984cited by this paper
• Carcinogenicity evaluation and regulatory decisions.

  1984cited by this paper
• 1984 Stokinger lecture. Some questions and opinions on issues in toxicology and risk assessment.

  1984cited by this paper
• Some Questions and Opinions on Issues in Toxicology and Risk Assessment

  1984cited by this paper
• Genotoxic activity and potency of 135 compounds in the Ames reversion test and in a bacterial DNA-repair test.

  1984cited by this paper
• A report of the U.S. Environmental Protection Agency Gene-Tox Program. Evaluation of mutagenicity assays for purposes of genetic risk assessment.

  1984cited by this paper
• Calculation of carcinogenic potency from long-term animal carcinogenesis experiments.

  1984cited by this paper
• OCCUPATIONAL CANCER: PROBLEMS IN INTERPRETING HUMAN EVIDENCE

  1984cited by this paper
• Design of animal carcinogenicity studies for goodness-of-fit of multistage models.

  1984cited by this paper
• Metabolism and relative carcinogenic potency of chloroethanes: a quantum chemical structure-activity study.

  1984cited by this paper
• Carcinogenesis in rats by nitrosodimethylamine and other nitrosomethylalkylamines at low doses.

  1984cited by this paper
• Use of Acute Toxicity to Estimate Carcinogenic Risk

  1984cited by this paper
• Summary of carcinogenicity data generated by the National Cancer Institute/National Toxicology Program.

  1984cited by this paper
• Structural features of nitroaromatics that determine mutagenic activity in Salmonella typhimurium.

  1984cited by this paper
• MUTAGENICITY AND CARCINOGENICITY CORRELATIONS BETWEEN BACTERIA AND RODENTS

  1983cited by this paper
• Olefin oxidation by cytochrome P-450: evidence for group migration in catalytic intermediates formed with vinylidene chloride and trans-1-phenyl-1-butene.

  1983cited by this paper
• Animal-human studies: an integrated approach to identifying hazardous chemicals in the workplace.

  1983cited by this paper
• Risk assessment by analysis of extrapolation error: A demonstration for effects of pollutants on fish

  1983cited by this paper
• Mutagenicity (Ames): a structure-activity model.

  1983cited by this paper
• Biological actions of nitroarenes in short-term tests on Salmonella, cultured mammalian cells and cultured human tracheal tissues: possible basis for regulatory control.

  1983cited by this paper
• Advantages of and problems with short-term mutagenicity tests for the assessment of mutagenic and carcinogenic risk.

  1983cited by this paper
• Overview of tumor promotion in animals

  1983cited by this paper
• The risks of drinking water

  1983cited by this paper
• Quantitative predictivity of the transformation in vitro assay compared with the Ames test.

  1983cited by this paper
• The power and interpretation of the carcinogenicity bioassay.

  1983cited by this paper
• Quantitative Approaches in Use to Assess Cancer Risk

  1983cited by this paper
• Comparative carcinogenic potencies of particulates from diesel engine exhausts, coke oven emissions, roofing tar aerosols and cigarette smoke.

  1983cited by this paper
• Principles of animal extrapolation

  1983cited by this paper
• Implication of nonlinear kinetics on risk estimation in carcinogenesis.

  1983cited by this paper
• The lifetime feeding study in mice and rats--an examination of its validity as a bioassay for human carcinogens.

  1983cited by this paper
• Olefin oxidation by cytochrome P-450: evidence for group migration in catalytic intermediates formed with vinylidene chloride and trans-1-phenyl-1-butene.

  1983cited by this paper
• Salmonella mutagenicity test results for 250 chemicals.

  1983cited by this paper
• A unifying concept for carcinogenic risk assessments.

  1983cited by this paper
• Mutagenic responses of thirteen anticancer drugs on mutation induction at multiple genetic loci and on sister chromatid exchanges in Chinese hamster ovary cells.

  1983cited by this paper
• Quantitative risk assessment: state-of-the-art for carcinogenesis.

  1983cited by this paper
• Induction of preneoplastic nodules: quantitative predictivity of carcinogenicity.

  1983cited by this paper
• Malignant conversion of mouse skin tumours is increased by tumour initiators and unaffected by tumour promoters

  1983cited by this paper
• The lifetime feeding study in mice and rats — An examination of its validity as a bioassay for human carcinogens

  1983cited by this paper
• A report on the workshop on biological and statistical implications of the ED01 study and related data bases.

  1983cited by this paper
• Tumor promotion by phorbol esters in skin: evidence for a memory effect.

  1983cited by this paper
• Trans-species and trans-tissue extrapolation of carcinogenicity assays.

  1983cited by this paper
• Toxicology and NTP Carcinogenesis Studies of a Polybrominated Biphenyl Mixture (Firemaster FF-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).

  1983cited by this paper
• Relative risk assessment; an aid to planning.

  1983cited by this paper
• The ranking of chemicals for carcinogenic potency.

  1983cited by this paper
• The Redundancy of Mouse Carcinogenicity Bioassays

  1983cited by this paper
• Structure-genotoxicity relationship for aliphatic epoxides.

  1983cited by this paper
• Comparison between carcinogenicity and mutagenicity based on chemicals evaluated in the IARC monographs.

  1983cited by this paper
• Chemical structure and carcinogenicity relationships of some chloroalkene oxides and their parent olefins.

  1983cited by this paper
• Risk Assessment in the Federal Government: Managing the Process

  1983cited by this paper
• Carcinogenesis: a predictive structure-activity model.

  1982cited by this paper
• EPA's high-risk carcinogen policy.

  1982cited by this paper
• Dose--response curve for ethylnitrosourea-induced specific-locus mutations in mouse spermatogonia.

  1982cited by this paper
• Use of relative toxicity for risk estimation

  1982cited by this paper
• Hydrocarbon bonds activated by complexes: Soluble metal complexes can activate normally unreactive bonds In alkanes to lose hydrogen and react In other ways under mild conditions

  1982cited by this paper

• 30 Carcinogenic potency: Statistical perspectives

  2000cites this paper
• On cancer risk estimation of urban air pollution.

  1994cites this paper
• Biological considerations for combining carcinogenicity data for quantitative risk assessment.

  1993cites this paper
• An overview of the report: correlation between carcinogenic potency and the maximum tolerated dose: implications for risk assessment.

  1993cites this paper
• Introduction to “Molecular Dosimetry”

  1993cites this paper
• A Weibull model for the estimation of tumorigenic potency.

  1993cites this paper
• DOSE-DEPENDENT PROMOTING EFFECT OF PHENOBARBITAL ON RAT HEPATOCARCINOGENESIS

  1992cites this paper
• Threshold dose dependence in phenobarbital promotion of rat hepatocarcinogenesis initiated by diethylnitrosamine.

  1992cites this paper
• Uncertainties in the risk assessment of three mycotoxins: aflatoxin, ochratoxin, and zearalenone.

  1990cites this paper
• Quantitative factors in chemical carcinogenesis: variation in carcinogenic potency.

  1990cites this paper
• Measuring Carcinogenic Potency1

  1990cites this paper
• Measuring carcinogenic potency.

  1990cites this paper
• A pragmatic approach to standard setting--the example of coal tar products and asphalt.

  1989cites this paper
• Critical Parameters in the Quantitation of the Stages of Initiation, Promotion, and Progression in One Model of Hepatocarcinogenesis in the Rat∗

  1989cites this paper
• Chemical risk assessment: a review.

  1989cites this paper
• The effects of dose and duration of administration on the promotion index of phenobarbital in multistage hepatocarcinogenesis in the rat.

  1988cites this paper
• Prediction of carcinogenic potency by short-term genotoxicity tests.

  1987cites this paper
• A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci.

  1987cites this paper
• A Retrospective Look at the Carcinogenic Potency of Vinyl Chloride

  1987cites this paper
• An approach to the determination of the relative potencies of chemical agents during the stages of initiation and promotion in multistage hepatocarcinogenesis in the rat.

  1987cites this paper
• Design and interpretation of bioassays for carcinogenicity.

  1987cites this paper